VistaGen Therapeutics Stock Forecast - Accumulation Distribution
| VTGN Stock | USD 0.62 0.03 4.62% |
VistaGen Stock outlook is based on your current time horizon.
As of today, the value of RSI of VistaGen Therapeutics' share price is approaching 30. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling VistaGen Therapeutics, making its price go up or down. Momentum 30
Sell Stretched
Oversold | Overbought |
Using VistaGen Therapeutics hype-based prediction, you can estimate the value of VistaGen Therapeutics from the perspective of VistaGen Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
VistaGen Therapeutics after-hype prediction price | USD 0.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of VistaGen Therapeutics to cross-verify your projections. To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.VistaGen Therapeutics Additional Predictive Modules
Most predictive techniques to examine VistaGen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VistaGen using various technical indicators. When you analyze VistaGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 23136.36 | 35307.14 |
| Check VistaGen Therapeutics Volatility | Backtest VistaGen Therapeutics | Information Ratio |
VistaGen Therapeutics Trading Date Momentum
| On January 26 2026 VistaGen Therapeutics was traded for 0.62 at the closing time. The top price for the day was 0.65 and the lowest listed price was 0.62 . The trading volume for the day was 765 K. The trading history from January 26, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 3.23% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare VistaGen Therapeutics to competition |
Other Forecasting Options for VistaGen Therapeutics
For every potential investor in VistaGen, whether a beginner or expert, VistaGen Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. VistaGen Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in VistaGen. Basic forecasting techniques help filter out the noise by identifying VistaGen Therapeutics' price trends.VistaGen Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VistaGen Therapeutics stock to make a market-neutral strategy. Peer analysis of VistaGen Therapeutics could also be used in its relative valuation, which is a method of valuing VistaGen Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
VistaGen Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how VistaGen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VistaGen Therapeutics shares will generate the highest return on investment. By undertsting and applying VistaGen Therapeutics stock market strength indicators, traders can identify VistaGen Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 35307.14 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 0.64 | |||
| Day Typical Price | 0.63 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.03) | |||
| Relative Strength Index | 30.51 |
VistaGen Therapeutics Risk Indicators
The analysis of VistaGen Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in VistaGen Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vistagen stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.76 | |||
| Standard Deviation | 11.87 | |||
| Variance | 140.87 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for VistaGen Therapeutics
The number of cover stories for VistaGen Therapeutics depends on current market conditions and VistaGen Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that VistaGen Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about VistaGen Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
VistaGen Therapeutics Short Properties
VistaGen Therapeutics' future price predictability will typically decrease when VistaGen Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of VistaGen Therapeutics often depends not only on the future outlook of the potential VistaGen Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VistaGen Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.7 M | |
| Cash And Short Term Investments | 80.5 M |
Check out Historical Fundamental Analysis of VistaGen Therapeutics to cross-verify your projections. To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VistaGen Therapeutics. If investors know VistaGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VistaGen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of VistaGen Therapeutics is measured differently than its book value, which is the value of VistaGen that is recorded on the company's balance sheet. Investors also form their own opinion of VistaGen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VistaGen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VistaGen Therapeutics' market value can be influenced by many factors that don't directly affect VistaGen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VistaGen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VistaGen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VistaGen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.